SteinCares

SteinCares and Shilpa Biologicals Strike into Licensing Agreement to Expand Access to Biosimilars Across Latin America

New partnership combines Shilpa Biologicals’ development and manufacturing capabilities with SteinCares’ regional commercialization platform Collaboration aims to expand patient access to cost-effective treatments and reinforces SteinCares’ leadership in biosimilars across Latin America Agreement marks the first product from this strategic partnership and Shilpa Biologicals' entry into the Latin American market. 10 March 2026 -- San...
San José, Escazú, Edificio Meridiano 5th floor, Costa Rica